The Australia Pavilion at the 2025 DIA China Annual Meeting is hosted by the Commercial Section of the Australian Embassy and Consulates in China, together with the Australian Trade and Investment Commission (Austrade). It serves as a key platform to showcase Australia’s strengths in clinical trials and biotechnology.
We invite you to visit Booth L16 at the Zhangjiang Science Hall in Shanghai from May 22 to 25 to meet 15 leading Australian companies, explore potential partnerships, and discuss opportunities in clinical trials and the development of new therapies.
Australia’s vibrant life sciences ecosystem comprises medtech, biotech, and pharmaceutical companies alongside world-renowned research institutions. With cutting-edge research infrastructure, generous financial incentives, a highly skilled global workforce, and a flexible regulatory environment, Australia is a premier destination for conducting clinical trials.
Austrade has also launched a WeChat Mini Program to facilitate online connections for those unable to attend in person, enabling seamless engagement with participating companies and institutions. We welcome your inquiries at any time.
Read More：
